LOINC Code 42084-4: Collaborative staging metastasis at diagnosis Cancer

What is this code?

LOINC codes identify tests, measurements, observations, survey items, and clinical questions in a standardized way. It is associated with the component Collaborative staging metastasis at diagnosis. It is commonly used with the system or sample type Cancer.XXX.

When is it used?

• Used in lab systems, EHRs, and clinical data exchange.
• May identify a test, observation, survey item, or clinical document request rather than a diagnosis.
• Status: ACTIVE

What it does not mean

• The code identifies the observation or test, not the actual result.

Key facts

• Collaborative staging metastasis at diagnosis Cancer
• Collaborative staging metastasis at diagnosis
• This belongs to the set of Collaborative Staging (CS) data items and is part of the detailed site-specific codes for anatomic EOD effective with 2004 diagnosis. It replaces data items 1090, 1100, and 1110 (Site of Distant Met 1-3). This modification for CS is collapsible into AJCC M code according to the sixth edition of AJCC Cancer Staging Manual. "CS Metastasis at Diagnosis" identifies the site(s) of metastatic involvement at time of diagnosis. Site-specific codes provide extensive detail describing disease extent. "CS Mets at DX" is used to derive the Derived AJCC M [2980], Derived AJCC Stage Group [3000], Derived SS1977 [3010], and Derived SS2000 [3020] codes. .. NAACCR Data Standards and Data Dictionary Version 11
• CA; CS; CS mets at Dx; Dx; Identity or presence; Metastases; Mets; Misc; Miscellaneous; Nominal; Oncology; Other; Point in time; Random; Spec; To be specified in another part of the message; TUMOR REGISTRY(NAACCR); Unspecified

Where you may see this code

You may see this code in lab systems, lab reports, EHR exports, interoperability feeds, or other structured clinical data exchanges.

Common synonyms

Frequently asked questions